Ayako Urabe

发表

Efficacy of vonoprazan 10 mg compared with 20 mg for the initial treatment in patients with erosive esophagitis: a randomized pilot study

R. Mouri, H. Okanobu, T. Kohno, 2020, Esophagus.

Ultra‐deep sequencing analysis of resistance‐associated variants during retreatment with simeprevir‐based triple therapy after failure of telaprevir‐based triple therapy in patients with genotype 1 hepatitis C virus infection

Y. Imai, N. Hayashi, N. Hiramatsu, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy

Y. Imai, N. Hayashi, N. Hiramatsu, 2016, Journal of medical virology.

Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response

Y. Imai, N. Hayashi, N. Hiramatsu, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients

Y. Imai, T. Kodama, Ryoko Yamada, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Histological findings and interferon treatment outcomes in patients with normal ALT levels and high viral load of HCV genotype 2

K. Chayama, H. Kohno, Ayako Urabe, 2007 .

Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension

K. Ohkawa, T. Kodama, Ryoko Yamada, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical outcomes of direct‐acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment

Y. Imai, N. Hiramatsu, K. Ohkawa, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg‐interferon, and ribavirin combination treatment for chronic hepatitis C

M. Imamura, N. Hiraga, K. Chayama, 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C

M. Imamura, N. Hiraga, K. Chayama, 2014, Journal of Gastroenterology.

The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients

M. Imamura, K. Chayama, H. Aikata, 2017, Journal of Gastroenterology.

Hepatocellular carcinoma occurrence does not differ between interferon‐based and interferon‐free treatment with liver histological assessment

Y. Imai, N. Hiramatsu, K. Ohkawa, 2019, Hepatology research : the official journal of the Japan Society of Hepatology.

Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all‐oral direct‐acting antivirals: Analysis of a Japanese prospective cohort

Y. Imai, K. Ohkawa, T. Kodama, 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

K. Awai, K. Chayama, H. Aikata, 2013, Journal of gastroenterology and hepatology.

Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection

Y. Imai, T. Kodama, Ryoko Yamada, 2020, PloS one.

Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C

M. Imamura, K. Chayama, H. Aikata, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Liver Fibrosis Is Associated With Corrected QT Prolongation During Ledipasvir/Sofosbuvir Treatment for Patients With Chronic Hepatitis C

Y. Imai, N. Hiramatsu, T. Kodama, 2018, Hepatology communications.

Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma

Y. Imai, N. Hiramatsu, K. Imanaka, 2020, Digestive Diseases and Sciences.

Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma

T. Kodama, M. Shigekawa, Ryoko Yamada, 2020, Hepatology research : the official journal of the Japan Society of Hepatology.

Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy

K. Awai, K. Chayama, H. Aikata, 2013, Journal of gastroenterology and hepatology.